Patents by Inventor Ji Duck Kim
Ji Duck Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220389010Abstract: The present invention relates to a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt thereof, and the compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions: in Chemical Formula 1, R1 to R3 are as defined in the present specification.Type: ApplicationFiled: November 25, 2020Publication date: December 8, 2022Inventors: Ji Duck Kim, Sun Ah Jun, Nam Youn Kim, In Woo Kim, Hyae Jung Hyun, Joon Seok Park
-
Patent number: 11084823Abstract: The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.Type: GrantFiled: March 19, 2018Date of Patent: August 10, 2021Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: In Woo Kim, Ja Kyung Yoo, Ji Duck Kim, Sun Ah Jun, Jun Hee Lee
-
Publication number: 20210130358Abstract: The present invention relates to a compound represented by the Chemical Formula 1 defined in the present specification, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.Type: ApplicationFiled: March 19, 2018Publication date: May 6, 2021Inventors: In Woo Kim, Ja Kyung Yoo, Ji Duck Kim, Sun Ah Jun, Jun Hee Lee
-
Patent number: 10961247Abstract: The present invention relates to a pyrazolopyrimidine derivative, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.Type: GrantFiled: June 30, 2017Date of Patent: March 30, 2021Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: In Woo Kim, Mi Ryeong Han, Jakyung Yoo, Yun Ju Oh, Ji Duck Kim, Nam Youn Kim, Sun Ah Jun, Jun Hee Lee, Joon Seok Park
-
Publication number: 20200317673Abstract: The present invention relates to a pyrazolopyrimidine derivative, or a pharmaceutically acceptable salt thereof. The compound according to the present invention can be usefully used for the prevention or treatment of diseases which are associated with kinase inhibitory actions.Type: ApplicationFiled: June 30, 2017Publication date: October 8, 2020Inventors: In Woo Kim, Mi Ryeong Han, Jakyung Yoo, Yun Ju Oh, Ji Duck Kim, Nam Youn Kim, Sun Ah Jun, Jun Hee Lee, Joon Seok Park
-
Patent number: 10590078Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and use thereof. The compound represented by the Formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof can be effectively used in the prevention or treatment of pains, for example, acute pain, chronic pain, pain from nervous disease, postoperative pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, paroxysmal extreme pain disorder (PEPD).Type: GrantFiled: February 11, 2016Date of Patent: March 17, 2020Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Ji Duck Kim, Hyung Geun Lee, Inwoo Kim, Sun Ah Jun, Myunggi Jung, Hyo Shin Kim
-
Publication number: 20180297948Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and use thereof. The compound represented by the Formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof can be effectively used in the prevention or treatment of pains, for example, acute pain, chronic pain, pain from nervous disease, postoperative pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, paroxysmal extreme pain disorder (PEPD).Type: ApplicationFiled: February 11, 2016Publication date: October 18, 2018Inventors: Ji Duck KIM, Hyung Geun LEE, Inwoo KIM, Sun Ah JUN, Myunggi JUNG, Hyo Shin KIM
-
Patent number: 10039747Abstract: The present invention provides tetrahydrocyclopentapyrrole derivatives that can be used for preventing or treating peptic ulcer, gastritis or reflux esophagitis, a method for preparing the same, and a pharmaceutical composition containing the same.Type: GrantFiled: August 29, 2014Date of Patent: August 7, 2018Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Kyung A Yu, Ji Sung Yoon, Deok Ki Eom, Yeon Im Lee, Mi Ryeong Han, Jun Hee Lee, Ha Nee Seo, Ji Duck Kim, Sang Ho Lee
-
Patent number: 9676714Abstract: Disclosed are a sulfonylindole derivative useful for the prevention or treatment of peptic ulcer, gastritis or reflux esophagitis, a method of preparing the same, and a pharmaceutical composition containing the same.Type: GrantFiled: October 2, 2014Date of Patent: June 13, 2017Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Kyung A Yu, Ji Sung Yoon, Deok Ki Eom, Yeon Im Lee, Hye Ryun Shin, Jun Hee Lee, Ha Nee Seo, Ji Duck Kim, Sang Ho Lee, Chun Ho Lee
-
Patent number: 9617216Abstract: The present invention relates to novel oxodihydropyridinecarbohydrazide derivatives with excellent antifungal activities, an antifungal composition containing the same, and its use for the prevention and treatment of fungal infectious diseases. The oxodihydropyridinecarbohydrazide derivatives of the present invention have excellent antifungal and fungicidal activities, and thus will be useful for the prevention and treatment of various fungal infections by Candida spp., Aspergillus spp., Cryptococcus neoformans and Trichophyton spp., etc. Additionally, the oxodihydropyridinecarbohydrazide derivatives of the present invention, unlike other fungicidal preparations, can be orally administered.Type: GrantFiled: October 21, 2014Date of Patent: April 11, 2017Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Joon Seok Park, Youn Jung Yoon, Chang Min Park, Yun Soo Na, Min Jae Cho, Ho Bin Lee, Mi Ryeong Han, Yeon Jung Park, Ji Duck Kim
-
Publication number: 20160304460Abstract: The present invention relates to novel oxodihydropyridinecarbohydrazide derivatives with excellent antifungal activities, an antifungal composition containing the same, and its use for the prevention and treatment of fungal infectious diseases. The oxodihydropyridinecarbohydrazide derivatives of the present invention have excellent antifungal and fungicidal activities, and thus will be useful for the prevention and treatment of various fungal infections by Candida spp., Aspergillus spp., Cryptococcus neoformans and Trichophyton spp., etc. Additionally, the oxodihydropyridinecarbohydrazide derivatives of the present invention, unlike other fungicidal preparations, can be orally administered.Type: ApplicationFiled: October 21, 2014Publication date: October 20, 2016Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.Inventors: Joon Seok Park, Youn Jung Yoon, Chang Min Park, Yun Soo Na, Min Jae Cho, Ho Bin Lee, Mi Ryeong Han, Yeon Jung Park, Ji Duck Kim
-
Publication number: 20160221946Abstract: Disclosed are a sulfonylindole derivative useful for the prevention or treatment of pepetic ulcer, gastritis or reflux esophagitis, a method of preparing the same, and a pharmaceutical composition containing the same.Type: ApplicationFiled: October 2, 2014Publication date: August 4, 2016Inventors: Kyung A. YU, Ji Sung YOON, Deok Ki EOM, Yeon Im LEE, Hye Ryun SHIN, Jun Hee LEE, Ha Nee SEO, Ji Duck KIM, Sang Ho LEE, Chun Ho LEE
-
Publication number: 20160200681Abstract: The present invention provides tetrahydrocyclopentapyrrole derivatives that can be used for preventing or treating peptic ulcer, gastritis or reflux esophagitis, a method for preparing the same, and a pharmaceutical composition containing the same.Type: ApplicationFiled: August 29, 2014Publication date: July 14, 2016Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.Inventors: Kyung A Yu, Ji Sung Yoon, Deok Ki Eom, Yeon Im Lee, Mi Ryeong Han, Jun Hee Lee, Ha Nee Seo, Ji Duck Kim, Sang Ho Lee
-
Patent number: 9376429Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).Type: GrantFiled: October 15, 2013Date of Patent: June 28, 2016Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Ha Young Kim, In Woo Kim, Sun Ah Jun, Yun Soo Na, Hyung Geun Lee, Min Jae Cho, Jun Hee Lee, Hyo Shin Kim, Yun Soo Yoon, Kyung Ha Chung, Ji Duck Kim
-
Patent number: 9199965Abstract: Disclosed herein are novel benzoimidazole derivatives functioning as antagonists to vanilloid receptor-1, and a pharmaceutical composition comprising the same. They are useful in preventing or treating pain, acute pain, chronic pain, neuropathic pain, postoperative pain, migraines, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neurological illness, neurodermatitis, strokes, bladder hypersensitivity, irritable bowel syndrome, respiratory disorders such as asthma, chronic obstructive pulmonary disease, etc., burns, psoriasis, itching, vomiting, irritation of the skin, eyes, and mucous membranes, gastric-duodenal ulcers, inflammatory intestinal diseases, and inflammatory diseases.Type: GrantFiled: January 27, 2006Date of Patent: December 1, 2015Assignee: Daewoong Co., Ltd.Inventors: Ji Duck Kim, Hong Chul Yoon, In Woo Kim, Hyae Jung Hyun
-
Publication number: 20150336944Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).Type: ApplicationFiled: October 15, 2013Publication date: November 26, 2015Inventors: Ha Young Kim, In Woo Kim, Sun Ah Jun, Yun Soo Na, Hyung Geun Lee, Min Jae Cho, Jun Hee Lee, Hyo Shin Kim, Yun Soo Yoon, Kyung Ha Chung, Ji Duck Kim
-
Patent number: 9040572Abstract: This invention relates to a method of preparing a benzoimidazole derivative at high purity and high yield so as to enable the production of the benzoimidazole derivative compound as an antagonist against a vanilloid reactor-1, and particularly to a method of preparing a benzoimidazole derivative at high purity and high yield, wherein the benzoimidazole derivative is synthesized using a novel intermediate, namely, benzaldehyde, and thereby the preparation process is simple so that it can be applied to production.Type: GrantFiled: September 27, 2011Date of Patent: May 26, 2015Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: In Woo Kim, Ji Duck Kim, Hong Chul Yoon, Hee Kyoon Yoon, Byung Goo Lee, Joon Hwan Lee, Young Mook Lim, Soo Jin Choi
-
Patent number: 8940769Abstract: Disclosed are biaryl benzoimidazole derivatives. They have an inhibitory effect on calcium influx in HEK cells, thereby showing a powerful antagonistic effect on a vanilloid receptor, and further have an analgesic effect, thereby being useful for preventing or treating pain, acute pain, chronic pain, neuropathic pain, postoperative pain, migraine, arthralgia, neuropathies, nerve injury, diabetic neuropathy, neurological illness, neurodermatitis, stroke, bladder hypersensitivity, irritable bowel syndrome, a respiratory disorder such as cough, asthma, and chronic obstructive pulmonary disease, burning, psoriasis, itching, vomiting, irritation of the skin, eyes, and mucous membranes, gastric-duodenal ulcers, inflammatory intestinal diseases, and inflammatory diseases.Type: GrantFiled: April 5, 2013Date of Patent: January 27, 2015Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Ji Duck Kim, Hong-Chul Yoon, In Woo Kim, Hyae Jung Hyun
-
Patent number: 8940768Abstract: Disclosed are novel triazole derivatives. Exhibiting excellent antifungal activity and in vivo safety, they are useful for the treatment or prevention of fungal infections caused by a wide spectrum of fungi.Type: GrantFiled: February 11, 2011Date of Patent: January 27, 2015Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Joon Seok Park, Kyung A Yu, Yun Soo Yoon, Mi Ryeong Han, Ji Duck Kim
-
Publication number: 20130231477Abstract: This invention relates to a method of preparing a benzoimidazole derivative at high purity and high yield so as to enable the production of the benzoimidazole derivative compound as an antagonist against a vanilloid reactor-1, and particularly to a method of preparing a benzoimidazole derivative at high purity and high yield, wherein the benzoimidazole derivative is synthesized using a novel intermediate, namely, benzaldehyde, and thereby the preparation process is simple so that it can be applied to production.Type: ApplicationFiled: September 27, 2011Publication date: September 5, 2013Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.Inventors: In Woo Kim, Ji Duck Kim, Hong Chul Yoon, Hee Kyoon Yoon, Byung Goo Lee, Joon Hwan Lee, Young Mook Lim, Soo Jin Choi